Jefferies Group LLC Intra Cellular Therapies, Inc. Put Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $81,006 - $146,556	-4,600 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $176,505 - $327,672	-12,300 Reduced 72.78%	4,600 $118,000
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $59.3 Million - $160 Million	-4,819,800 Reduced 99.65%	16,900 $260,000
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $34.3 Million - $182 Million	4,725,500 Added 4249.55%	4,836,700 $166 Million
Q3 2019 Nov 13, 2019	BUY	$7.47 - $14.03 $774,639 - $1.45 Million	103,700 Added 1382.67%	111,200 $831,000
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $79,875 - $107,175	7,500 New	7,500 $97,000
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $2.55 Million - $3 Million	-178,700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1.92 Million - $3.95 Million	178,700	178,700 $2.82 Million

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.